NASDAQ:OPTH Optimi Health (OPTH) Stock Price, News & Analysis $4.02 0.00 (0.00%) As of 10/9/2026 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsNews and TrendsSEC Filings About Optimi Health Stock (NASDAQ:OPTH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Optimi Health alerts:Sign Up Key Stats Today's Range$4.00▼$4.2050-Day Range$4.02▼$5.1552-Week Range$4.00▼$6.40Volume21,409 shsAverage Volume44,528 shsMarket Capitalization$23.03 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingReduce Company Overview Optimi Health Corp. is a Canadian life sciences company focused on the development and production of psychedelic and functional mushroom products. The company’s work centers on naturally sourced compounds, including psilocybin, for potential applications in mental health and wellness. Optimi operates a production and research facility in Princeton, British Columbia, where it develops mushroom-based formulations and related products. Its activities have included the cultivation, extraction, formulation and packaging of products intended for clinical research, therapeutic development and consumer wellness markets, subject to applicable regulatory requirements. The company serves customers and research partners primarily from Canada and is also focused on opportunities in international markets as regulations governing psychedelic medicines and mushroom-derived products evolve. Optimi Health is led by Chief Executive Officer Bill Ciprick, who has been associated with the company since its early development.AI Generated. May Contain Errors. Read More Optimi Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks7th Percentile Overall ScoreOPTH MarketRank™: Optimi Health scored higher than 7% of companies evaluated by MarketBeat, and ranked 866th out of 882 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingReduce Consensus RatingOptimi Health has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageOptimi Health has only been the subject of 1 research reports in the past 90 days.Read more about Optimi Health's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Optimi Health is -5.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Optimi Health is -5.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.51% of the float of Optimi Health has been sold short.Short Interest Ratio / Days to CoverOptimi Health has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Optimi Health has recently increased by 43.67%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldOptimi Health does not currently pay a dividend.Dividend GrowthOptimi Health does not have a long track record of dividend growth. News and Social Media1.6 / 5News Sentiment0.60 News SentimentOptimi Health has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Optimi Health this week, compared to 3 articles on an average week.MarketBeat FollowsOnly 1 people have added Optimi Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company OwnershipN/AInsider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Optimi Health insiders have not sold or bought any company stock.Percentage Held by InstitutionsOptimi Health has minimal institutional ownership at this time.Read more about Optimi Health's insider trading history. Receive OPTH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Optimi Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OPTH Stock News HeadlinesOptimi Health to Present at the ThinkEquity ConferenceOctober 7, 2026 | financialpost.comFOptimi Health to Present at the ThinkEquity ConferenceOctober 7, 2026 | globenewswire.comYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today. | Profits Run (Ad)Optimi Health Corp. Appoints Melanie Pump to Board of DirectorsSeptember 29, 2026 | quiverquant.comQOptimi Health Appoints Melanie Pump to Board of DirectorsSeptember 29, 2026 | globenewswire.comOptimi Health Completes Psilocybin Production for Health Canada-Approved Phase 2 MDD Trial and Commercial TRD SupplySeptember 23, 2026 | financialpost.comFOptimi Health Completes Psilocybin Production for Health Canada-Approved Phase 2 MDD Trial and Commercial TRD SupplySeptember 23, 2026 | globenewswire.comOptimi Health Corp. Appoints Michael Blough as Chief Clinical Development Officer to Advance Psychedelic Clinical TrialsSeptember 22, 2026 | quiverquant.comQSee More Headlines OPTH Stock Analysis - Frequently Asked Questions How have OPTH shares performed this year? Optimi Health's stock was trading at $6.08 on May 20, 2026. Since then, OPTH stock has decreased by 33.9% and is now trading at $4.02. When did Optimi Health's stock split? Shares of Optimi Health reverse split before market open on Wednesday, May 20th 2026.A 1-30 reverse split was announced. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, May 19th 2026. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. When did Optimi Health IPO? Optimi Health (OPTH) raised $15 million in an initial public offering (IPO) on Wednesday, May 20th 2026. The company issued 2,400,000 shares at a price of $6.25 per share. Joseph Gunnar & Co. served as the underwriter for the IPO. When does Optimi Health's lock-up period expire? Optimi Health's lock-up period expires on Monday, November 16th. Optimi Health had issued 2,400,000 shares in its public offering on May 20th. The total size of the offering was $15,000,000 based on an initial share price of $6.25. After the end of Optimi Health's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted. How do I buy shares of Optimi Health? Shares of OPTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today10/11/2026The ThinkEquity Conference10/15/2026Fiscal Year End9/30/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:OPTH CIK2027329 Webwww.optimihealth.ca Phone778-761-4551FaxN/AEmployees9Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.04 Current Ratio0.06 Quick Ratio0.03 Sales & Book Value Annual Sales$310 thousand Price / Sales74.31 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares5,730,000Free FloatN/AMarket Cap$23.03 million OptionableN/A BetaN/A 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NASDAQ:OPTH) was last updated on 10/9/2026 by MarketBeat.com Staff. From Our PartnersFree Ticker: Anthropic's silent partner could soar after record $2 trillion IPOAnthropic's IPO prospectus just leaked, revealing 261 pages tied to a record $2 trillion valuation. Beyond ...Monument Traders Alliance | SponsoredUrgent Attention to Executive Order #14363 (Buy This Stock Before Oct. 20thMarc Chaikin, a 60-year Wall Street veteran whose past clients include George Soros and Steve Cohen, built a s...Chaikin Analytics | SponsoredA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredUrgent: Invest In ‘Elon’s iPhone’ Before July 22ndEarly Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | SponsoredI've seen this movie before (last time: 17,556%)My track record speaks for itself... KDA: 17,556%. PRE: 3,900%. OCEAN: 2,650%. Every single one was called ...Crypto 101 Media | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredGold did this exact thing in 1975… [then exploded]In 1975 the Fed raised rates and gold fell 50 percent. Headlines called the gold bull market dead. Instead gol...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Optimi Health Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Optimi Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
